Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation

Hypertension Research

Volumn 36, Issue 6, 2013, Pages 496-503

  Zouein, Fouad A ^a   Zgheib, Carlos ^a   Hamza, Shereen ^a   Fuseler, John W ^b   Hall, John E ^a   Soljancic, Andrea ^a   Lopez Ruiz, Arnaldo ^a   Kurdi, Mazen ^a,c   Booz, George W ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c LEBANESE UNIVERSITY   (Lebanon)

Author keywords

cardiac hypertrophy; cardiac remodeling; cytokines; fibrosis; heart failure; myofibrils

Indexed keywords

ANGIOTENSIN II; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC IMAGING; CELL STRUCTURE; CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HISTOLOGY; HYPERTENSION; MOUSE; MUSCLE FIBRIL; NONHUMAN; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; COLLAGEN; CYTOKINES; ELECTROCARDIOGRAPHY; FIBROSIS; HEART; HEMODYNAMICS; HYPERTENSION; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; SERINE; STAT3 TRANSCRIPTION FACTOR; VASOCONSTRICTOR AGENTS;

EID: 84878911382     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.223     Document Type: Article

References (37)

1. Booz GW. Left ventricular physiology in hypertension. In Lip YH, Hall JE (eds), Comprehensive Hypertension. Mosby: Philadelphia, 2007, pp 113-121.
2. Bolli R, Stein AB, Guo Y, Wang OL, Rokosh G, Dawn B, Molkentin JD, Sanganalmath SK, Zhu Y, Xuan YT. A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J Mol Cell Cardiol 2011; 50: 589-597.
3. Oshima Y, Fujio Y, Nakanishi T, Itoh N, Yamamoto Y, Negoro S, Tanaka K, Kishimoto T, Kawase I, Azuma J. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Cardiovasc Res 2005; 65: 428-435. (Pubitemid 40082485)
4. Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, Wu WJ, Tan W, Bolli R. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 2004; 64: 61-71. (Pubitemid 39208923)
5. Xuan YT, Guo Y, Zhu Y, Han H, Langenbach R, Dawn B, Bolli R. Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J Mol Cell Cardiol 2003; 35: 525-537. (Pubitemid 36539458)
6. Negoro S, Kunisada K, Fujio Y, Funamoto M, Darville MI, Eizirik DL, Osugi T, Izumi M, Oshima Y, Nakaoka Y, Hirota H, Kishimoto T, Yamauchi-Takihara K. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/ reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 2001; 104: 979-981. (Pubitemid 32803871)
7. Osugi T, Oshima Y, Fujio Y, Funamoto M, Yamashita A, Negoro S, Kunisada K, Izumi M, Nakaoka Y, Hirota H, Okabe M, Yamauchi-Takihara K, Kawase I, Kishimoto T. Cardiacspecific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart. J Biol Chem 2002; 277: 6676-6681. (Pubitemid 34968469)
8. Haghikia A, Stapel B, Hoch M, Hilfiker-Kleiner D. STAT3 and cardiac remodeling. Heart Fail Rev 2011; 16: 35-47.
9. Lindner D, Hilbrandt M, Marggraf K, Becher PM, Hilfiker-Kleiner D, Klingel K, Pauschinger M, Schultheiss HP, Tschope C, Westermann D. Protective Function of STAT3 in CVB3-Induced Myocarditis. Cardiol Res Pract 2012; 2012: 437623.
10. Jacoby JJ, Kalinowski A, Liu MG, Zhang SS, Gao Q, Chai GX, Ji L, Iwamoto Y, Li E, Schneider M, Russell KS, Fu XY. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci USA 2003; 100: 12929-12934. (Pubitemid 37340002)
11. Zgheib C, Zouein FA, Kurdi M, Booz GW. Differential STAT3 Signaling in the Heart: Impact of Concurrent Signals and Oxidative Stress. JAK-STAT 2012; 1: 102-111.
12. Shen Y, Schlessinger K, Zhu X, Meffre E, Quimby F, Levy DE, Darnell Jr JE. Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol Cell Biol 2004; 24: 407-419. (Pubitemid 38010065)
13. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011; 146: 353-358.
14. Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 2006; 48: 58-64. (Pubitemid 44297525)
15. Walter Jr RJ, Berns MW. Digital Image Processing and Analysis. In Inoue S (ed.), Video Microscopy. Plenum Press: New York and London, 1986, pp 327-392.
16. Fuseler JW, Valarmathi MT. Modulation of the migration and differentiation potential of adult bone marrow stromal stem cells by nitric oxide. Biomaterials 2012; 33: 1032-1043.
17. Fuseler JW, Millette CF, Davis JM, Wayne Carver W. Fractal and image analysis of morphological changes in the actin cytoskeleton of neonatal cardiac fibroblasts in response to mechanical stretch. Microsc Microanal 2007; 13: 128-132.
18. Fuseler JW, Bedenbaugh A, Krishna Y, Baudino TA. Fractal and Image Analysis of the microvasculature in normal intestinal submucosa and intestinal polyps in ApcMin/ Mice. Microsc Microanal 2010; 16: 73-79.
19. Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE, Ikeda U. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res 2006; 99: 891-899. (Pubitemid 44556389)
20. Mascareno E, Galatioto J, Rozenberg I, Salciccioli L, Kamran H, Lazar JM, Liu F, Pedrazzini T, Siddiqui MA. Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor b (TGF-b1) signaling axis. J Biol Chem 2012; 287: 13084-13093.
21. Sano M, Fukuda K, Kodama H, Takahashi T, Kato T, Hakuno D, Sato T, Manabe T, Tahara S, Ogawa S. Autocrine/Paracrine secretion of IL-6 family cytokines causes angiotensin II-induced delayed STAT3 activation. Biochem Biophys Res Commun 2000; 269: 798-802. (Pubitemid 30440380)
22. Hamdani N, Borbe ly A, Veenstra SP, Kooij V, Vrydag W, Zaremba R, Dos Remedios C, Niessen HW, Michel MC, Paulus WJ, Stienen GJ, van der Velden J. More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease. J Muscle Res Cell Motil 2010; 31: 289-301.
23. Bito V, van der Velden J, Claus P, Dommke C, Van Lommel A, Mortelmans L, Verbeken E, Bijnens B, Stienen G, Sipido KR. Reduced force generating capacity in myocytes from chronically ischemic, hibernating myocardium. Circ Res 2007; 100: 229-237. (Pubitemid 46208723)
24. Iwasaki J, Nakamura K, Matsubara H, Nakamura Y, Nishii N, Banba K, Murakami M, Ohta-Ogo K, Kimura H, Toh N, Nagase S, Oka T, Morita H, Kusano KF, Ohe T. Relationship between circulating levels of monocyte chemoattractant protein-1 and systolic dysfunction in patients with hypertrophic cardiomyopathy. Cardiovasc Pathol 2009; 18: 317-322.
25. Kai H, Mori T, Tokuda K, Takayama N, Tahara N, Takemiya K, Kudo H, Sugi Y, Fukui D, Yasukawa H, Kuwahara F, Imaizumi T. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertens Res 2006; 29: 711-718. (Pubitemid 44605370)
26. Melendez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 2010; 56: 225-231.
27. Wenzel S, Taimor G, Piper HM, Schlu ter KD. Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-b expression in adult ventricular cardiomyocytes. FASEB J 2001; 15: 2291-2293.
28. Zhao F, Xuan Z, Liu L, Zhang MQ. TRED: a Transcriptional Regulatory Element Database and a platform for in silico gene regulation studies. Nucleic Acids Res 2005; 33: D103-D1037.
29. Modesti PA, Vanni S, Bertolozzi I, Cecioni I, Polidori G, Paniccia R, Bandinelli B, Perna A, Liguori P, Boddi M, Galanti G, Serneri GG. Early sequence of cardiac adaptations and growth factor formation in pressure-and volume-overload hypertrophy. Am J Physiol Heart Circ Physiol 2000; 279: H976-H985.
30. Cambi GE, Lucchese G, Djeokeng MM, Modesti A, Fiaschi T, Faggian G, Sani G, Modesti PA. Impaired JAK2-induced activation of STAT3 in failing human myocytes. Mol Biosyst 2012; 8: 2351-2359.
31. Brands MW, Banes-Berceli AK, Inscho EW, Al-Azawi H, Allen AJ, Labazi H. Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation. Hypertension 2010; 56: 879-884.
32. Banes-Berceli AK, Al-Azawi H, Proctor D, Qu H, Femminineo D, Hill-Pyror C, Webb RC, Brands MW. Angiotensin II utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake. Am J Physiol Regul Integr Comp Physiol 2011; 301: R1169-R1176.
33. Serneri GG, Boddi M, Cecioni I, Vanni S, Coppo M, Papa ML, Bandinelli B, Bertolozzi I, Polidori G, Toscano T, Maccherini M, Modesti PA. Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 2001; 88: 961-968. (Pubitemid 32441476)
34. Kurdi M, Booz GW. Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling. J Cardiovasc Pharmacol 2007; 50: 126-141. (Pubitemid 47267738)
35. Oba T, Yasukawa H, Hoshijima M, Sasaki K, Futamata N, Fukui D, Mawatari K, Nagata T, Kyogoku S, Ohshima H, Minami T, Nakamura K, Kang D, Yajima T, Knowlton KU, Imaizumi T. Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2012; 59: 838-852.
36. Szczepanek K, Chen Q, Larner AC, Lesnefsky EJ. Cytoprotection by the modulation of mitochondrial electron transport chain: The emerging role of mitochondrial STAT3. Mitochondrion 2012; 12: 180-189.
37. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, Moh A, Moghaddas S, Chen Q, Bobbili S, Cichy J, Dulak J, Baker DP, Wolfman A, Stuehr D, Hassan MO, Fu XY, Avadhani N, Drake JI, Fawcett P, Lesnefsky EJ, Larner AC. Function of mitochondrial Stat3 in cellular respiration. Science 2009; 323: 793-797.